Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-6.42%
↓ 115% vs avg
Percentile
P50
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
43.87%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -6.42% |
| Q3 2025 | 21.71% |
| Q2 2025 | -8.62% |
| Q1 2025 | -39.46% |
| Q4 2024 | -65.86% |
| Q3 2024 | 26.27% |
| Q2 2024 | -2.61% |
| Q1 2024 | 24.98% |
| Q4 2023 | -103.98% |
| Q3 2023 | -113.28% |
| Q2 2023 | 867.43% |
| Q1 2023 | -29.90% |
| Q4 2022 | 0.00% |